Back to COLL
GOLDMAN SACHS GROUP INC → COLL
GOLDMAN SACHS GROUP INC COLL Position History
Collegium Pharmaceutical, Inc. • Healthcare
Quarters held
15
Latest value
$242K
Q3 2026
Peak value
$21M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $2.4M |
| Q2 2025 | $4.6M |
| Q3 2025 | $20.1M |
| Q3 2025 | $8M |
| Q4 2025 | $9M |
| Q4 2025 | $21M |
| Q4 2025 | $21M |
| Q4 2025 | $9M |
| Q1 2026 | $15.3M |
| Q1 2026 | $3.7M |
| Q2 2026 | $15.6M |
| Q2 2026 | $4.5M |
| Q3 2026 | $5.1M |
| Q3 2026 | $10M |
| Q3 2026 | $242K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $242K | 11.1K | — | — |
| Q3 2026 | $10M | 456.3K | — | — |
| Q3 2026 | $5.1M | 234.1K | — | — |
| Q2 2026 | $4.5M | 125.0K | — | — |
| Q2 2026 | $15.6M | 431.9K | — | — |
| Q1 2026 | $3.7M | 111.2K | — | — |
| Q1 2026 | $15.3M | 463.9K | — | — |
| Q4 2025 | $9M | 194.4K | — | — |
| Q4 2025 | $21M | 453.1K | — | — |
| Q4 2025 | $21M | 453.1K | — | — |
| Q4 2025 | $9M | 194.4K | — | — |
| Q3 2025 | $8M | 227.4K | — | — |
| Q3 2025 | $20.1M | 574.8K | — | — |
| Q2 2025 | $4.6M | 156.8K | — | — |
| Q2 2025 | $2.4M | 80.0K | — | — |
Other funds holding COLL
$190.4M
$171.7M
$160.1M
$157.7M
$136.8M
$134.2M
$114.2M